Radiotherapy-free neoadjuvant strategy using sintilimab plus XELOX in locally advanced rectal cancer: A single-arm phase II trial

Figure 3 Analysis of multifactorial clinical risk assessment factors. A: Changes of before treatment T stage to after treatment T stage in 41 patients who reached the surgery; B: Changes of before treatment N stage to after treatment N stage in 41 patients who reached the surgery; C: Rectal magnetic resonance imaging evaluation of pathological complete response rate patients before and after treatment; D: Rectal magnetic resonance imaging evaluation of non-pathological complete response rate patients before and after treatment. In C and D, the orange arrows indicate tumor location and size, with the left arrows representing pre-treatment findings and the right arrows representing post-treatment findings.